Most Recent
Kmart has been ordered to produce more documents related to changes made to the designs for its men's cargo pants and shorts in a lawsuit alleging it violated the copyright for workwear company Globe International's clothing designs.
The judge overseeing the lengthy trial between agricultural giants Cargill and Viterra over the $420 million sale of malt producer Joe White has shot down Viterra's request to shield the identity of malting companies that allegedly engaged in shady business practices, including using a banned substance to produce malt.
Executives of Facebook, Google and Twitter could be looking at new Australian laws carrying jail terms if they don't do more to stop the live streaming of violence on their social media platforms.
Electricity retailer Click Energy has been ordered to pay $900,000 in penalties for misleading consumers about discounts on their energy bills.
AMP will challenge the admissibility of an expert report central to ASIC's case over alleged insurance churning by one of the wealth manager's former financial advisers, after a judge called on the regulator to be more transparent about its communication with the experts in the case.
Trader Daniel Schlaepfer and his firm Select Vantage were alerted to possible market manipulation and flaws in the company's surveillance system, the court has heard mid-trial in the case alleging ASIC made defamatory remarks to the trading firm's major business partners.
IP Australia has challenged a patent application for a rearward-facing car seat, despite shooting down all the grounds of opposition raised by child safety product maker Dorel.
Aspiring MP Clive Palmer has filed his defence against a lawsuit by US record label Universal Music over his take on the 1980s rock anthem 'We're Not Gonna Take It', saying he didn't infringe any copyright on the song because it's not original.
The general manager of service station chain Westside Petroleum has been named in a lawsuit by the Fair Work Ombudsman alleging the company shortchanged workers more than $62,000.
Pharmaceutical giant Mylan has been ordered to hand over documents relating to its proposed launch of a generic version of its cholesterol drug Lipidil to rival Sun Pharma in advance of a hearing on Mylan's request for an order blocking Sun from launching its own generic version of the drug.